Correlation Between Qs Moderate and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Qs Moderate and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qs Moderate and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qs Moderate Growth and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Qs Moderate and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qs Moderate with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qs Moderate and Franklin Biotechnology.

Diversification Opportunities for Qs Moderate and Franklin Biotechnology

-0.19

Correlation Coefficient

Qs Moderate  Franklin Biotechnology

Good diversification

The 3 months correlation between SCGCX and Franklin is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Qs Moderate Growth and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Qs Moderate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qs Moderate Growth are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Qs Moderate i.e., Qs Moderate and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Qs Moderate and Franklin Biotechnology

Assuming the 90 days horizon Qs Moderate Growth is expected to generate 0.46 times more return on investment than Franklin Biotechnology. However, Qs Moderate Growth is 2.18 times less risky than Franklin Biotechnology. It trades about 0.11 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.03 per unit of risk. If you would invest  1,549  in Qs Moderate Growth on September 28, 2024 and sell it today you would earn a total of  292.00  from holding Qs Moderate Growth or generate 18.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Qs Moderate Growth  vs.  Franklin Biotechnology Discove

Qs Moderate Growth

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Qs Moderate Growth are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Qs Moderate is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Qs Moderate and Franklin Biotechnology

The main advantage of trading using opposite Qs Moderate and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qs Moderate position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Qs Moderate Growth and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.